ES403317A1 - Therapeutic composition - Google Patents

Therapeutic composition

Info

Publication number
ES403317A1
ES403317A1 ES403317A ES403317A ES403317A1 ES 403317 A1 ES403317 A1 ES 403317A1 ES 403317 A ES403317 A ES 403317A ES 403317 A ES403317 A ES 403317A ES 403317 A1 ES403317 A1 ES 403317A1
Authority
ES
Spain
Prior art keywords
therapeutic composition
triiodothyroacetic acid
appropriate
constituents
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES403317A
Other languages
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
THERANOL LAB
Original Assignee
THERANOL LAB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by THERANOL LAB filed Critical THERANOL LAB
Publication of ES403317A1 publication Critical patent/ES403317A1/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/66—Enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/06—Preparations for care of the skin for countering cellulitis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Birds (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

Procedure for the solubilization of therapeutic compositions based on L-thyroxine and 3-3-5-triiodothyroacetic acid, associated with a diffusion factor such as hyaluronidase, characterized in that it consists in dissolving the three aforementioned constituents of the composition in a vehicle appropriate, at the same time solvent for said active constituents, and in particular 3-3-5-triiodothyroacetic acid, and miscible with water, adding an appropriate wetting agent. (Machine-translation by Google Translate, not legally binding)
ES403317A 1971-06-03 1972-05-30 Therapeutic composition Expired ES403317A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7120183A FR2139748B1 (en) 1971-06-03 1971-06-03

Publications (1)

Publication Number Publication Date
ES403317A1 true ES403317A1 (en) 1976-04-01

Family

ID=9078067

Family Applications (1)

Application Number Title Priority Date Filing Date
ES403317A Expired ES403317A1 (en) 1971-06-03 1972-05-30 Therapeutic composition

Country Status (8)

Country Link
JP (1) JPS5212779B1 (en)
BE (1) BE784267A (en)
CA (1) CA982477A (en)
CH (1) CH572744A5 (en)
DE (1) DE2226927A1 (en)
ES (1) ES403317A1 (en)
FR (1) FR2139748B1 (en)
GB (1) GB1354263A (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH622703A5 (en) * 1976-06-10 1981-04-30 Berema Sa Therapeutic compositions for treating deposits of excess fat and infiltrates causing cellulite
US4525359A (en) * 1982-12-10 1985-06-25 Greenway Frank L Iii Treatment for selective weight control
EP0831769B2 (en) * 1995-06-07 2008-07-23 Lavin, Dr., Thomas N. Novel uses for thyroid hormones or thyroid hormone-like compounds
US6380255B1 (en) 1995-06-07 2002-04-30 Karo Bio Ab Treatment for dermal skin atrophy using thyroid hormone compounds or thyroid hormone-like compounds
GB2457710A (en) * 2008-02-25 2009-08-26 Andrew Nicolaou Thyroxine and its use in weight loss and obesity treatment

Also Published As

Publication number Publication date
FR2139748B1 (en) 1974-08-30
CA982477A (en) 1976-01-27
FR2139748A1 (en) 1973-01-12
BE784267A (en) 1972-12-01
GB1354263A (en) 1974-06-05
DE2226927A1 (en) 1973-01-18
JPS5212779B1 (en) 1977-04-09
CH572744A5 (en) 1976-02-27

Similar Documents

Publication Publication Date Title
ES396288A1 (en) Light protection agent for cosmetic purposes
ES296969A1 (en) Shellac tablet coating compositions and methods of preparation
ES403317A1 (en) Therapeutic composition
ES294061A1 (en) Method for the concentration of thixotropic compositions (Machine-translation by Google Translate, not legally binding)
FR1715M (en) Therapeutic composition.
ES302412A1 (en) Herbicidal composition and method
ES376357A1 (en) S-alkyl-(methylhexahydro-1h-azepine)-1-carbothiolates
ES349900A1 (en) A procedure for the preparation of pharmaceutical compositions of chlorosured steroids. (Machine-translation by Google Translate, not legally binding)
ES297027A1 (en) Improvements in obtaining explosive compositions (Machine-translation by Google Translate, not legally binding)
Fletcher The development of small-scale farming in New South Wales (excluding Norfolk Island), 1787 to 1803
ES256730A1 (en) An apparatus for agricultural uses (Machine-translation by Google Translate, not legally binding)
FR2282M (en) 6 alpha-chloro-16 alpha-methyl-progesterone useful in particular as an anti-estrogenic agent.
BE606205A (en) New pharmaceutical compositions comprising 5-nitro-8-hydroxy-quinoline as well as its halogenated derivatives in position 7.
ES260812A1 (en) Improvements in the obtaining of antichriptogram compositions (Machine-translation by Google Translate, not legally binding)
ES78747U (en) Rotating platform for gastronomic services (Machine-translation by Google Translate, not legally binding)
FR1636M (en) Injectable bihormonal composition, useful in particular as an anti-abortion drug.
ES268307A3 (en) Improvements introduced in the construction of auto vehicle frames (Machine-translation by Google Translate, not legally binding)
ES349821A1 (en) Improvements in or relating to Agricultural Compositions
ES157775U (en) Perfected therapeutic suppository. (Machine-translation by Google Translate, not legally binding)
ES364913A1 (en) Procedure for stabilizing a composition of a polyolefin (Machine-translation by Google Translate, not legally binding)
ES228970A1 (en) Improvements introduced in the preparation of nematocidal compositions (Machine-translation by Google Translate, not legally binding)
ES360073A1 (en) Procedure for the preparation of vasodilator compositions. (Machine-translation by Google Translate, not legally binding)
ES336947A1 (en) Improvements introduced in the preparation of asbestos compositions. (Machine-translation by Google Translate, not legally binding)
ES263915A3 (en) Procedure for obtaining hormones and vitamins, especially b 12 of slow effect via via injectable (Machine-translation by Google Translate, not legally binding)
ES272932A3 (en) Improvements introduced in the preparation of compositions intended for the purpose of sterilization, disinfection, oxidation and blanking (Machine-translation by Google Translate, not legally binding)